These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21144990)

  • 1. Fungal sepsis: optimizing antifungal therapy in the critical care setting.
    Lepak A; Andes D
    Crit Care Clin; 2011 Jan; 27(1):123-47. PubMed ID: 21144990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidemia in the critically ill patient.
    Picazo JJ; González-Romo F; Candel FJ
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
    Devlin RK
    Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive fungal infections in the intensive care unit.
    Vazquez JA
    Semin Respir Crit Care Med; 2010 Feb; 31(1):79-86. PubMed ID: 20101550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective analysis of invasive fungal infection in surgical intensive care unit].
    Li S; An YZ
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):382-5. PubMed ID: 20367934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida resistance and its clinical relevance.
    Klepser ME
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):68S-75S. PubMed ID: 16716125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical critical care: fungal infections in surgical patients.
    Lipsett PA
    Crit Care Med; 2006 Sep; 34(9 Suppl):S215-24. PubMed ID: 16917426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
    Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
    CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of candidemia in intensive care units.
    Bouza E; Muñoz P
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal therapy for neonatal candidiasis.
    Zaoutis T; Walsh TJ
    Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia.
    Tumbarello M; Posteraro B; Trecarichi EM; Sanguinetti M
    Arch Intern Med; 2009 Aug; 169(15):1444-5; author reply 1445. PubMed ID: 19667313
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
    Natarajan G; Lulic-Botica M; Aranda JV
    J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.